: T-Cell Receptor Beta Gene Rearrangement Analysis, Blood or Bone Marrow

: What This Test Looks At

: T cells are a type of white blood cell that normally carry many different T-cell receptors, creating a broad, varied mix. The TCR beta gene rearrangement test examines the DNA that codes for part of this receptor to see whether the T cells are diverse or dominated by one clone. A clone is a group of identical cells arising from a single cell.

: Why It Is Ordered

: Your doctor may order this test when a T-cell lymphoma or leukemia is suspected, or to help monitor a known T-cell disorder. It is often used alongside blood counts, flow cytometry, and tissue biopsy to give a fuller picture. Results are interpreted together with these other findings.

: How the Sample Is Collected

: The test is usually performed on a blood sample or a bone marrow sample, and sometimes on tissue from a lymph node or other affected area. A healthcare professional collects the specimen using standard procedures. The laboratory then extracts DNA and analyzes the T-cell receptor beta gene.

: Understanding the Result

: A clonal (monoclonal) result means one T-cell population dominates, which can support a diagnosis of a T-cell cancer but is not proof on its own. A polyclonal (diverse) result is more typical of a normal or reactive process. Some conditions can show clonal results without cancer, and some cancers may not show a clone, so the result is always interpreted with other tests and your clinical history.